COVID-19: Commission authorizes second adapted vaccine for member states’ autumn vaccination campaigns
The European Medicines Agency (EMA) carried out a stringent evaluation of the vaccine under the accelerated assessment mechanism. Following this evaluation, the Commission authorised the adapted vaccine under an expedited procedure so that member states can prepare in time for their autumn-winter vaccination campaigns.
A press release is available online.
Share this article: